BioCentury
ARTICLE | Company News

BioHelix, Quidel deal

October 12, 2009 7:00 AM UTC

BioHelix will use its isothermal amplification technology to develop assays for in vitro molecular diagnostics for infectious pathogens. Quidel will fund assay development and have exclusive, worldwid...